|
Guidelines for Covariate Adjustment in RCTs
|
|
62
|
35312
|
October 9, 2022
|
|
Sample size linear regression
|
|
3
|
3394
|
September 18, 2022
|
|
Study Design for Subjective Multinomial Outcome
|
|
7
|
3745
|
June 6, 2022
|
|
What type of study design can best describe this Study?
|
|
0
|
1710
|
June 2, 2022
|
|
Predictive modelling of crossover trial with a binary outcome and four interventions
|
|
0
|
1571
|
May 12, 2022
|
|
Prospective OR Retrospective Cohort Study?
|
|
3
|
5142
|
May 8, 2022
|
|
Is logistic regression or survival analysis most appropriate in this case?
|
|
1
|
2294
|
April 28, 2022
|
|
Statistical power estimation for a time-dependent covariate in Cox (proportional hazards) regression
|
|
0
|
2009
|
April 19, 2022
|
|
Outcome dispersion and reduction of outliers as a primary outcome in clinical RCT?
|
|
3
|
2475
|
February 24, 2022
|
|
RCT - baseline measures and group x time interaction without main effect for group?
|
|
6
|
6569
|
January 1, 2022
|
|
Some help needed regarding how to conduct an external validation study
|
|
0
|
2204
|
December 23, 2021
|
|
Step Wedge study design with continuous outcome in the Covid era
|
|
7
|
3767
|
November 28, 2021
|
|
Sample Size for Bland Altman plot
|
|
1
|
6024
|
October 17, 2021
|
|
Sample size calculations - exact vs. approximate
|
|
0
|
2935
|
October 6, 2021
|
|
Sample size determination for observational studies
|
|
6
|
15023
|
October 4, 2021
|
|
Concrete examples of the pre-planned analysis going wrong
|
|
16
|
5065
|
August 24, 2021
|
|
Early phase dose finding studies - inviting perspectives on 3+3 versus dose titration
|
|
8
|
13346
|
July 24, 2021
|
|
Designing numerical stimuli
|
|
0
|
2794
|
July 7, 2021
|
|
Default Using R package to implement Bayesian phase I/II dose-finding design for three outcomes
|
|
10
|
4427
|
June 10, 2021
|
|
Bootstrap and prior distribution method for self-controlled case series design
|
|
0
|
2387
|
June 9, 2021
|
|
Fully sequential Bayesian clinical trial design for in-hospital treatment of COVID-19
|
|
23
|
12907
|
June 7, 2021
|
|
Debunking myths: intention to treat , missing follow-up and imputation
|
|
6
|
4830
|
March 15, 2021
|
|
Sample size requirements for a proportional odds model
|
|
7
|
7783
|
March 15, 2021
|
|
Devising a database
|
|
7
|
5590
|
February 23, 2021
|
|
Value stream mapping - numbers needed
|
|
0
|
3120
|
February 8, 2021
|
|
Power Analysis for 3 Groups and 3 Measures
|
|
1
|
4042
|
February 7, 2021
|
|
DAGs for Bayesian hierarchical models?
|
|
4
|
8743
|
January 8, 2021
|
|
Sample size estimation
|
|
6
|
6235
|
November 14, 2020
|
|
RCT trials for COVID study vaccines
|
|
0
|
3256
|
October 24, 2020
|
|
"Open label, double-masked trial"
|
|
0
|
3738
|
October 13, 2020
|